Breaking News

Ajinomoto Bio-Pharma, Gene Tools Partner to Broaden Access to PMOs

Gene Tools will provide pre-purified PMO synthesis, while Aji Bio-Pharma will perform purification and quality control.

Author Image

By: Charlie Sternberg

Associate Editor

Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, and Gene Tools, LLC have partnered to broaden access to phosphorodiamidate morpholino oligomers (PMOs), a unique class of oligonucleotide therapeutics with significant potential for treating a broad range of genetic diseases, such as Duchenne muscular dystrophy (DMD). This partnership addresses a critical gap in the development pipeline by enabling purified PMO production at early r...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters